ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.1400
-0.0121 (-7.99%)
At close: Nov 18, 2025
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $1.13 million as of November 19, 2025. Its market cap has decreased by -47.51% in one year.
Market Cap
1.13M
Enterprise Value
1.06M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 1.13M, a decrease of -98.81%. That is a compound annual growth rate of -69.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 1.23M | -53.67% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
| Feb 10, 2022 | 95.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 790.31M |
| Elite Pharmaceuticals | 605.00M |
| Glass House Brands | 434.20M |
| American Oncology Network | 412.69M |
| Northwest Biotherapeutics | 374.98M |
| CytoDyn | 362.81M |
| Silence Therapeutics | 318.83M |
| Nika Pharmaceuticals | 311.89M |